Studies

CellWell record HH-19237

Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial

Fung EB; Kwiatkowski JL; Huang JN; Gildengorin G; King JC; Vichinsky EP

The American Journal of Clinical Nutrition ยท 2013

In plain language

In 42 people with thalassemia and low bone mass, 25 mg of zinc daily for 18 months produced significantly greater gains in whole-body bone mineral content and density than placebo.

Evidence
Established
Design
Randomized controlled trial
Studied in
Human

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-19237

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.